tiprankstipranks
Trending News
More News >
National Health Investors (NHI)
NYSE:NHI
Advertisement

National Health Investors (NHI) AI Stock Analysis

Compare
697 Followers

Top Page

NHI

National Health Investors

(NYSE:NHI)

Rating:79Outperform
Price Target:
$86.00
▲(9.69% Upside)
National Health Investors is performing well with strong financials, positive technical indicators, and a promising earnings call. The company's strategic focus on growth and a recent dividend increase further enhance its attractiveness. However, a relatively high P/E ratio suggests caution regarding valuation.
Positive Factors
Earnings
FAD earnings beat expectations highlighted by strong SHOP SSNOI growth.
Guidance
Guidance was bumped above the Street, benefiting from solid acquisition momentum.
Revenue
REVPOR is improving, which indicates a positive trend in revenue per occupied room.
Negative Factors
Operational Challenges
Bickford's occupancy has also slipped, indicating potential operational challenges.

National Health Investors (NHI) vs. SPDR S&P 500 ETF (SPY)

National Health Investors Business Overview & Revenue Model

Company DescriptionIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
How the Company Makes MoneyNational Health Investors generates revenue primarily through leasing its healthcare properties to operators, who pay rent based on long-term lease agreements. The company typically structures its leases to include fixed rent increases, ensuring a steady and predictable income stream. Additionally, NHI may earn income through mortgage financing and property management services. Key revenue streams include rental income from its diverse portfolio of properties, which consists of independent living, assisted living, and skilled nursing facilities. The company's strategic partnerships with experienced healthcare operators enhance its operational efficiency and tenant stability, contributing to its overall financial performance. NHI's focus on the growing demand for senior housing and healthcare services positions it well within a market with favorable long-term trends.

National Health Investors Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 11, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong financial performance, growth in SHOP segment, increased guidance, and a dividend hike, indicating positive momentum. However, recent softness in SHOP occupancy and challenges with Discovery leases present some concerns. Overall, the positive aspects outweigh the negatives.
Q2-2025 Updates
Positive Updates
Strong Quarterly Performance and Guidance Increase
NHI exceeded expectations in Q2 2025 with strong acquisition pace, SHOP NOI growth, and improved tenant fundamentals. As a result, the 2025 guidance for normalized FFO per share was raised by $0.09 to $4.80, indicating a year-over-year growth of 8.1%.
Dividend Increase
For the first time in 4 years, NHI announced a dividend increase, reflecting confidence in sustained growth and shareholder value.
SHOP Segment Expansion
Transitioned 7 properties to SHOP, increasing annualized SHOP NOI by approximately $8.8 million or 57%. SHOP now represents nearly 10% of NHI's consolidated NOI, with expectations of continued growth.
Pipeline and Acquisitions
NHI has announced $175 million in investments in 2025 and has $130 million under signed LOIs. The pipeline is strong with approximately $350 million focused on senior housing.
Healthy Balance Sheet
NHI's net debt to adjusted EBITDA stands at 3.9x with available liquidity of approximately $760 million, facilitating future growth opportunities.
Negative Updates
Occupancy Softness in SHOP Segment
There was some recent softness in occupancy in the SHOP segment, attributed to local leadership changes and abnormal move-outs.
Discovery Lease Termination
NHI expects to write off approximately $12 million in straight-line receivables associated with the termination of Discovery leases.
Company Guidance
During the second quarter of 2025, National Health Investors (NHI) reported robust financial performance, driven by strategic acquisitions and strong SHOP (Senior Housing Operating Portfolio) growth. The company increased its midpoint normalized FFO (Funds From Operations) guidance per share by $0.09 to $4.80, signifying an 8.1% year-over-year growth. NHI's SHOP NOI (Net Operating Income) surged by over 29% compared to the same quarter in 2024, and the transition of seven properties to SHOP increased annualized NOI by $8.8 million, enhancing SHOP's share of consolidated NOI to nearly 10%. The company also announced a 2.2% dividend increase, the first in four years, and maintained a strong balance sheet with a net debt to adjusted EBITDA ratio of 3.9x and available liquidity of approximately $760 million. Looking forward, NHI projects double-digit NOI growth for 2026, with $175 million in investments announced and an additional $130 million under signed LOIs, emphasizing a significant focus on senior housing acquisitions, particularly within SHOP.

National Health Investors Financial Statement Overview

Summary
National Health Investors showcases a solid financial standing with consistent revenue and profit growth, strong profitability margins, and efficient cash flow management. The balance sheet is stable, though leverage is moderately high, which is typical in the REIT industry. The company is well-positioned for future growth, but must continue to manage its debt levels carefully to mitigate financial risk.
Income Statement
78
Positive
The company's gross profit margin remains strong, hovering around 96.7% in TTM, indicating efficient cost management. The net profit margin increased to approximately 41.2% in TTM, demonstrating improved profitability. Revenue growth has been consistent, with a TTM increase to $342.97 million from $335.18 million in the prior annual period. EBIT and EBITDA margins are also robust, reflecting healthy operational performance. However, the growth rate has slowed compared to earlier periods, suggesting potential saturation.
Balance Sheet
75
Positive
The debt-to-equity ratio is approximately 0.89 in TTM, indicating moderate leverage for a REIT. The return on equity improved to nearly 9.9% in TTM, showing effective utilization of shareholder funds. The equity ratio is stable at about 51.2%, reflecting a solid capital structure. While the debt level is significant, the company maintains a favorable equity position, balancing risk and potential returns.
Cash Flow
82
Very Positive
The company demonstrates a strong cash flow position with a consistent rise in free cash flow, up 2.8% in TTM. The operating cash flow to net income ratio is approximately 1.51, indicating efficient cash generation relative to net income. Free cash flow to net income ratio is robust at 1.48, underscoring the firm's capacity to generate cash above net earnings. Overall, cash flow management is a significant strength.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue349.38M335.18M319.83M278.19M298.71M332.81M
Gross Profit306.91M324.02M308.32M268.41M287.08M323.16M
EBITDA273.56M264.16M259.94M151.99M212.99M303.95M
Net Income142.93M137.99M135.65M23.06M62.19M135.37M
Balance Sheet
Total Assets2.70B2.61B2.49B2.51B2.84B3.12B
Cash, Cash Equivalents and Short-Term Investments18.64M24.29M22.35M19.29M37.41M43.34M
Total Debt0.001.15B1.14B1.15B1.25B1.51B
Total Liabilities1.20B1.23B1.21B1.22B1.32B1.60B
Stockholders Equity1.48B1.37B1.25B1.27B1.51B1.51B
Cash Flow
Free Cash Flow209.95M203.70M180.71M180.71M210.79M218.29M
Operating Cash Flow212.50M207.77M184.45M185.34M210.86M232.15M
Investing Cash Flow-286.56M-192.31M-11.63M197.94M185.28M-89.71M
Financing Cash Flow76.48M-13.57M-169.72M-401.25M-402.99M-111.76M

National Health Investors Technical Analysis

Technical Analysis Sentiment
Positive
Last Price78.40
Price Trends
50DMA
73.17
Positive
100DMA
72.93
Positive
200DMA
71.31
Positive
Market Momentum
MACD
1.39
Positive
RSI
66.68
Neutral
STOCH
63.03
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHI, the sentiment is Positive. The current price of 78.4 is above the 20-day moving average (MA) of 76.49, above the 50-day MA of 73.17, and above the 200-day MA of 71.31, indicating a bullish trend. The MACD of 1.39 indicates Positive momentum. The RSI at 66.68 is Neutral, neither overbought nor oversold. The STOCH value of 63.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NHI.

National Health Investors Risk Analysis

National Health Investors disclosed 43 risk factors in its most recent earnings report. National Health Investors reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

National Health Investors Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$7.61B28.208.36%3.68%50.84%104.44%
79
Outperform
$3.67B24.6610.49%4.59%6.87%7.23%
75
Outperform
$1.68B19.958.94%6.23%8.18%-16.83%
74
Outperform
$4.58B24.996.66%6.31%6.89%240.70%
70
Neutral
$7.29B-1.51%2.34%11.62%
63
Neutral
$7.02B13.41-0.50%6.86%4.08%-25.24%
49
Neutral
$2.67B-25.97%6.94%27.66%18.03%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NHI
National Health Investors
78.40
-0.23
-0.29%
LTC
LTC Properties
36.62
2.29
6.67%
SBRA
Sabra Healthcare REIT
19.03
2.81
17.32%
MPW
Medical Properties
4.61
-0.13
-2.74%
CTRE
CareTrust REIT
33.94
5.28
18.42%
AHR
American Healthcare REIT, Inc.
42.73
21.08
97.37%

National Health Investors Corporate Events

Financial Disclosures
National Health Investors Releases Q2 2025 Financial Insights
Neutral
Aug 6, 2025

National Health Investors, Inc. has released its supplemental information for the quarter ended June 30, 2025. The report provides insights into the company’s financial performance, including adjusted segment NOI and real estate investments, highlighting the company’s focus on senior housing and medical facilities. The report also outlines various risks and uncertainties that could impact future performance, such as environmental laws, liability claims, and economic effects from international trade disputes.

Business Operations and Strategy
National Health Investors Releases Investor Update Presentation
Neutral
Aug 6, 2025

On August 6, 2025, National Health Investors, Inc. issued an investor update presentation available on their website. This update provides insights into the company’s operations and strategic positioning, highlighting potential impacts on stakeholders and the real estate investment trust industry.

Business Operations and Strategy
National Health Investors Updates Investment Pipeline Strategy
Positive
Jun 2, 2025

On June 2, 2025, National Health Investors, Inc. issued an investor presentation updating its investment pipeline to approximately $331.4 million, with $126.7 million in signed letters of intent, including a $71 million investment in senior housing operating partnerships. This update reflects NHI’s strategic focus on expanding its investment portfolio, potentially impacting its market positioning and offering insights into future growth opportunities for stakeholders.

Executive/Board ChangesShareholder Meetings
National Health Investors Holds 2025 Annual Meeting
Neutral
May 28, 2025

On May 21, 2025, National Health Investors, Inc. held its 2025 Annual Meeting of Stockholders, where 80.26% of the company’s common stock was represented. During the meeting, four directors were elected, an amendment to declassify the board was approved, executive compensation was affirmed, and BDO USA, P.C. was ratified as the independent auditor for 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025